Xanthine oxidase inhibition for the improvement of long-term outcomes following ischaemic stroke and transient ischaemic attack (XILO-FIST) – Protocol for a randomised double blind placebo-controlled clinical trial

BACKGROUND: Allopurinol, a xanthine oxidase inhibitor, reduced progression of carotid-intima media thickness and lowered blood pressure in a small clinical trial in people with ischaemic stroke. Xanthine oxidase inhibition for improvement of long-term outcomes following ischaemic stroke and transien...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur Stroke J
Hlavní autoři: Dawson, Jesse, Broomfield, Niall, Dani, Krishna, Dickie, David A, Doney, Alex, Forbes, Kirsten, Houston, Graeme, Kean, Sharon, Lees, Kennedy, McConnachie, Alex, Muir, Keith W, Quinn, Terry, Struthers, Allan, Walters, Matthew
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2018
Témata:
Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6120121/
https://ncbi.nlm.nih.gov/pubmed/30246149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2396987318771426
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky